DRAG

Research

Our web-based applications support pharmaceutical companies in early HTA planning and submissions. Estima has developed web-based apps for SLRs and analysis tools for connected networks and single arm trials with IPD used both for early HTA planning and directly in HTA submissions.

Filter:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Peer Reviewed Articles

No results match the filters.
No results match the filters. Reset all filters

Reports

No results match the filters.
No results match the filters. Reset all filters

Conference Abstracts

No results match the filters.

HTA156 Assessing the Generalizability of Automating Adaptation of Excel-Based Cost-Effectiveness Models Using Generative AI

Rawlinson 2024
Value in Health
W Rawlinson, S Teitsson, T Reason, B Malcolm, A Gimblett, S Klijn

Objectives

A previous study (ISPOR 2024, P48) described a method ‘LLMAdapt’ that uses a large language model (LLM) to automatically adjust an Excel-based cost-effectiveness model (CEM) from the setting of one country to another. The authors found a high level of accuracy (97%) for one test case. Assessment of generalizability is an important step for uptake and acceptance of AI-based methods by decision-makers. The objective of this study was to assess the generalizability of LLMAdapt across two distinct disease areas and countries.

Methods

LLMAdapt (powered by Generative Pre-trained Transformer 4 [the gpt-4-1106-preview model]) was used to automatically adjust two HTA-ready Excel CEMs from the setting of one country to the setting of another. To support the adaptations, GPT-4 was provided with tabular data for each of the target countries in a format that mimicked the output of a targeted literature review. Prior to conducting the study, each CEM received minor updates to improve its interpretability, such as clarifying vague descriptive text. The models spanned the following disease areas: muscle-invasive urothelial carcinoma (MIUC) and myelodysplastic syndrome (MDS) and were adapted to the following countries: the Czech Republic and the United States. All automated adaptations were manually checked by a human health economist to assess accuracy.

Results

The adaptations were performed without human intervention in 132 and 207 seconds. LLMAdapt performed 101/102 and 198/199 required updates successfully, resulting in accuracy scores of 99.0% and 99.4%. Two errors were identified, in which required parameter value changes were missed.

Conclusions

We found that the accuracy of LLMAdapt was maintained across two distinct disease areas and countries, demonstrating the generalizability of LLM-based methods to automate the adaptation of Excel-based CEMs. This is an important step towards uptake of these methods.

Cite This Article

HTA156 Assessing the Generalizability of Automating Adaptation of Excel-Based Cost-Effectiveness Models Using Generative AI Rawlinson, W. et al. Value in Health, Volume 27, Issue 12, S384. https://doi.org/10.1016/j.jval.2024.10.1981

Read Paper
Automating Economic Models

Let’s talk

Get in touch with our team below and discover how Estima can help you:

Start your journey
Start your journey
We’ll be in touch soon
Oops! Something’s gone wrong, please try again